赛托生物：预计2025年净利润亏损6300万元-8800万元

Core Viewpoint - The company expects a net profit loss of 63 to 88 million yuan for the fiscal year 2025 due to declining product prices and increased R&D expenses [1] Group 1: Financial Performance - The overall gross profit margin of the company's products has decreased year-on-year due to falling market prices [1] - The company has increased its R&D investment during the reporting period, contributing to the reduction in net profit [1] - Significant inventory impairment provisions were made for several intermediate products due to price declines, impacting current profits [1]